Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressive and antitumor properties of new histone deacetylase inhibitor WF-27082B

May 31, 2000

Enzo Biochem's tolerance induction therapy may be useful in GVHD

May 31, 2000

SciClone's Zadaxin now available in Italy

May 31, 2000

L-Glu-L-Trp analogues with advantages over parent compound

May 29, 2000

Use of verteporfin for improving xenograft transplant survival

May 26, 2000

Chiron's Fluad influenza vaccine approved under E.U. mutual recognition procedure

May 25, 2000

Isotechnika's new immunosuppressive drug successfully completes phase Ia

May 25, 2000

SERP-1: potential synergy with ciclosporin indicated by preclinical results

May 22, 2000

Targeted immunosuppression of alloreactive cells achieved with OX-40 immunotoxins

May 22, 2000

C220, a novel chimeric anti-CD40 MAb, prolongs renal allograft survival in primates

May 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...